Showing all 9 results
Darifenacin Prolonged Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Finasteride USP/Ph.Eur. 1 mg The Global Dermatology Standard: The definitive micro-dose engineered specifically for the lifelong, daily maintenance of Androgenetic Alopecia (Male Pattern Hair Loss). Finasteride USP/Ph.Eur. 5 mg The Global Urology Standard: High-efficacy macro-dose utilized for the aggressive shrinkage of the prostate gland in symptomatic Benign Prostatic Hyperplasia (BPH). Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Docusate Sodium / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Opadry Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the teratogenic API, ensuring absolute safety for female pharmacists and caregivers handling the medication) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strict, lifelong chronic urology and dermatology dispensing regimens).
Flavoxate HCL Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Flavoxate Hydrochloride USP/Ph.Eur. 200 mg The Global Urological Standard: The definitive macrodose therapeutic unit utilized for rapid, acute suppression of agonizing bladder spasms and chronic overactive bladder maintenance. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 200mg tablet shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-4 times daily acute dispensing regimens).
Mirabegron Extended-Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Nitrofurantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.
Active Ingredient Strength Primary Clinical Function Nitrofurantoin (Macrocrystals) USP/Ph.Eur. 50 mg Prophylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing. Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP 100 mg Global Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis. Excipients Carbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Phenazopyridine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.
Active Ingredient Strength Primary Clinical Function Phenazopyridine HCl USP/Ph.Eur. 100 mg OTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief. Phenazopyridine HCl USP/Ph.Eur. 200 mg Prescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax Coating Diluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).
SILODOSIN 8 MG TABLET
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Tamsulosin 0.4 mg tablet
FreeA Tamsulosin 0.4 mg tablet (or capsule) is a selective alpha-1 adrenergic receptor antagonist used to treat symptoms of an enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH).
